Edgewise Therapeutics Inc (EWTX)

followers · Follow

Sector:

HEALTH CARE

Industry:

BIOTECHNOLOGY & LIFE SCIENCES

CEO:

Kevin Koch

Employees:

1715 38TH ST, BOULDER, CO, 80301

720-262-7002

edgewisetx.com

Edgewise Therapeutics, Inc. develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy.

	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change

Edgewise Therapeutics Inc YCharts
Yahoo! Finance	finviz

Shareholders (13F, 13D/G)

Current Mutual Fund/ETF Holders

Active 13D/G Filings

SEC Filings

Insiders

Short Positions

Congress

Proposed Sales

Comments and Updates

To Excel | To CSV | To TSV

Investor	History	Shares Held or Principal Amt	Market Value	% of Portfolio	Previous % of Portfolio	Rank	Change in Shares	% Ownership	Qtr 1st Owned	Est. Avg Price	Source	Source Date	Date Reported
No data available